Literature DB >> 1523168

Synthesis and in vitro evaluation of [Leu13]porcine motilin fragments.

M J Macielag1, T L Peeters, Z D Konteatis, J R Florance, I Depoortere, R A Lessor, L A Bare, Y S Cheng, A Galdes.   

Abstract

Several peptide fragments representing N-terminal, C-terminal, and internal sequences of [Leu13]porcine motilin ([Leu13]pMOT) were synthesized using Fmoc solid phase methodology. Peptides were assayed for motilin receptor binding activity in a rabbit antrum smooth muscle preparation and for stimulation of contractile activity in segments of rabbit duodenum. In vitro activity was directly correlated with motilin receptor binding affinity for all [Leu13]pMOT fragments examined. N-Terminal fragments of just over half the length of the native peptide are nearly equipotent as full-length motilin. These results suggest that the N-terminal segment, together with residues from the mid-portion of the molecule, constitutes the bioactive portion of pMOT. The C-terminal segment, in contrast, contributes little to receptor binding affinity or in vitro activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1523168     DOI: 10.1016/0196-9781(92)90090-p

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  3 in total

1.  Maximum entropy reconstruction of joint phi, psi-distribution with a coil-library prior: the backbone conformation of the peptide hormone motilin in aqueous solution from phi and psi-dependent J-couplings.

Authors:  Tariq Massad; Jüri Jarvet; Risto Tanner; Katrin Tomson; Julia Smirnova; Peep Palumaa; Mariko Sugai; Toshiyuki Kohno; Kalju Vanatalu; Peter Damberg
Journal:  J Biomol NMR       Date:  2007-04-26       Impact factor: 2.835

2.  Effect of atilmotin, a motilin receptor agonist, on esophageal, lower esophageal sphincter, and gastric pressures.

Authors:  Annapurna Korimilli; Henry P Parkman
Journal:  Dig Dis Sci       Date:  2010-02       Impact factor: 3.199

Review 3.  Ghrelin and motilin receptors as drug targets for gastrointestinal disorders.

Authors:  Gareth J Sanger; John B Furness
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-22       Impact factor: 46.802

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.